{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-147674","form_type":"8-K","ticker":"NDSN","cik":"0000072331","company_name":"NORDSON CORP","filed_at":"2024-05-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.782104+00:00","generated_at":"2026-06-01T08:26:53.996296+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Nordson to acquire Atrion for $460/share in cash, ~$800M enterprise value","bullets":["Deal price $460/share cash; enterprise value ~$800M; 15x 2024 estimated EBITDA including expected synergies.","Atrion 2023 revenue ~$169M; key businesses: Halkey Roberts, Atrion Medical, Quest Medical in infusion and cardiovascular.","Expected close before Nordson fiscal year-end Oct 2024; funded by cash on hand and new debt.","Three FDA-registered U.S. manufacturing facilities expand Nordson MEDICAL's addressable market."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-147674","json":"https://secwatch.observer/filing/0001193125-24-147674.json","markdown":"https://secwatch.observer/filing/0001193125-24-147674.md","text":"https://secwatch.observer/filing/0001193125-24-147674.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/72331/000119312524147674/0001193125-24-147674-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/72331/000119312524147674/d836379d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T08:26:53.996296+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}